Impact of iron/folate versus multi-micronutrient supplementation during pregnancy on birth weight: a randomised controlled trial in rural Western China
- Conditions
- ow birth weightpreterm deliveryanaemiaPregnancy and ChildbirthDisorders related to length of gestation and fetal growth
- Registration Number
- ISRCTN08850194
- Lead Sponsor
- nited Nations Children's Fund (UNICEF) (China)
- Brief Summary
2008 Results article in http://www.ncbi.nlm.nih.gov/pubmed/18996930 results 2009 Results article in http://www.ncbi.nlm.nih.gov/pubmed/19589154 results 2012 Results article in http://www.ncbi.nlm.nih.gov/pubmed/22085869 30-month follow-up results 2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/26084366 results 2016 Results article in http://www.ncbi.nlm.nih.gov/pubmed/27449363 results 2018 Results article in http://www.ncbi.nlm.nih.gov/pubmed/29987336 results 2020 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31395416 results (added 12/08/2019) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36527827/ 14-year follow-up (added 19/12/2022)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 5828
Women invited to participate in the trial must be less than 28 weeks of gestation
Women will be excluded from the trial if already taking iron, folate, and other micronutrients supplements for more than two weeks
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> 1. Duration of pregnancy<br> 2. Birth weight, length and head circumference<br> 3. Haemoglobin level of pregnant women at the start of their third trimester<br>
- Secondary Outcome Measures
Name Time Method <br> 1. Compliance with supplements<br> 2. Side effects of supplements<br> 3. Complications of pregnancy:<br> 3.1. Hypertension and preeclampsia<br> 3.2. Antepartum haemorrhage<br> 3.3. Infections<br> 4. Type of delivery and type of assistance<br> 5. Delivery complications:<br> 5.1. Prolonged labour<br> 5.2. Postpartum haemorrhage<br> 5.3. Duration of maternal hospital admission<br> 6. Early neonatal morbidity<br>